ADVANCING ORAL THERAPEUTICS TO TRANSFORM THE TREATMENT OF CANCER AND INFLAMMATION

RAPT Therapeutics is focused on the development of oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing our proprietary discovery platform, we are developing highly selective small molecules that are designed to modulate the critical immune responses underlying these diseases.